|
Claude Hughes, Ph.D., is vice president for the Consortium for Molecular Epidemiology, Genomics, Environment and Health (MEGEH) and RTI’s chief medical officer. Before RTI, Dr. Hughes was executive director of Medical and Scientific Services at Quintiles and is the North American strategic medical and scientific director for the Quintiles-Solvay Partnership. He is adjunct professor in the Department of Pathology/Comparative Medicine at Wake Forest University, adjunct professor in the Department of Biology at East Carolina University, and consulting professor in the Department of Obstetrics and Gynecology at Duke University. Before joining Quintiles, Dr. Hughes held positions in reproductive endocrinology and infertility within departments of obstetrics and gynecology and clinical and research centers of university-affiliated medical centers. He is specialty board certified in obstetrics and gynecology and subspecialty board certified in reproductive endocrinology and infertility. His research has examined the effects of natural and man-made sex hormone-like compounds in the diet in laboratory animal and human studies. | 